Recently, we highlighted that the ganglioside GM1 promotes neuroblastoma cells differentiation by activating the TrkA receptor through the formation of a TrkA-GM1 oligosaccharide complex at the cell surface. To study the TrkA-GM1 interaction, we synthesized two radioactive GM1 derivatives presenting a photoactivable nitrophenylazide group at the end of lipid moiety, 1 or at position 6 of external galactose, 2; and a radioactive oligosaccharide portion of GM1 carrying the nitrophenylazide group at position 1 of glucose, 3. The three compounds were singly administered to cultured neuroblastoma Neuro2a cells under established conditions that allow cell surface interactions. After UV activation of photoactivable compounds, the proteins were analyzed by PAGE separation. The formation of cross-linked TrkA-GM1 derivatives complexes was identified by both radioimaging and immunoblotting.
Gangliosides, together with cholesterol, have been described as the driving molecules necessary to organize the cellular membranes with heterogeneous lipid distribution and to be responsible for the first steps of lipid rafts formation (Sonnino et al. 2006) . In the lipid rafts, gangliosides can interact with proteins modulating their physical and functional properties .
The ganglioside GM1, marker of plasma membrane lipid rafts, has been described to play key functional roles in numerous events (Ledeen and Wu 2015; Schengrund 2015; Aureli et al. 2016) . GM1 is one of the main components of the brain ganglioside pattern and many papers have elucidated its role as neurotrophic and neuroprotective molecule in in vitro and in in vivo models, comprising humans (Schneider et al. 2010 (Schneider et al. , 2013 Ledeen and Wu 2018a,b) .
GM1 exerts its well-known properties through the activation of plasma membrane receptors (Ledeend and Wu 2018a, b) ; nevertheless, understanding whether the activity of a protein is determined by the ganglioside influence on membrane organization or by a direct ganglioside-protein interaction (Coskun and Simons 2011 ) is a hard challenge. However, the synthesis of tritium-labeled and photoactivable gangliosides and their administration to cells in culture allows to study the ganglioside-protein interactions (Bisson and Montecucco 1981; Sonnino et al. 1989; Mauri et al. 2004) . Indeed, after administration to the cells under dark conditions, these ganglioside derivatives are taken up by the cells becoming component of the plasma membranes and metabolically indistinguishable, from the endogenous compounds (Sonnino et al. 1989) . Cell illumination produces a very reactive derivative containing nitrene capable to react with the molecules in the neighboring environment and forming a covalent linkage. Thus, proteins, interacting with the activated ganglioside, form a stable tritium-labeled complex that can be identified by radioimaging technic after protein separation (Loberto et al. 2003; Mauri et al. 2004; Prioni et al. 2004; Chiricozzi et al. 2015) . A detailed structural analysis of the complex allows to identify the involved protein.
Using this strategy in combination with other biochemical approaches, here, we studied how the ganglioside GM1 and the TrkA receptor interact in cultured neuroblastoma cells in vitro.
This interaction acts as a trigger for the activation of intracellular signaling cascades that ultimately produce cell differentiation and cell protection from toxic compounds. In this view, neurotrophic and neuroprotective properties, long since attributed to GM1 (Mutoh et al. 1995; Chiricozzi et al. 2017) , find, at least in part, a molecular explanation. In this paper, we present data suggesting that GM1-TrkA interaction occurs between the extracellular moiety of TrkA that, probably lying upon the cells, reaches the oligosaccharide head of the GM1 whose ceramide portion is inserted in a membrane domain different from the receptor ones.
Methods

Materials
Commercial chemicals were of the highest purity available, common solvents were distilled before use, and water was doubly distilled in a glass apparatus.
Cell culture plates and Transfectagro TM reduced serum medium were from Corning (Corning, NY, USA). Mouse neuroblastoma Neuro2a (N2a) cells (RRID:CVCL_0470), phosphate-buffered saline (PBS), HPR-conjugated cholera toxin subunit B (CT-B), o-phenylenediamine tablets, H 2 O 2 , vibrio cholerae sialidase, 2-propanol, formic acid, Ponceau S, 3-(4,5,-dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide (MTT), and bovine serum albumin (BSA) were from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's modified Eagle's high glucose medium (DMEM-HG), fetal bovine serum (FBS), L-glutamine (L-Glut), penicillin (10.000 Units/mL), streptomycin, and 30% acrylamide were from EuroClone (Paignton, UK). Rabbit anti-TrkA (RRID:AB_10695253), rabbit anti-phospho-TrkA (Tyr490) (RRID:AB_10235585), rabbit anti-p44/42 MAPK (ERK1/ 2) (RRID: AB_390779), rabbit anti-phospho-p44/42 MAPK (p-ERK1/2) (Thr202/Tyr204) (RRID: AB_2315112), and anti-rabbit IgG (RRID: AB_2099233) antibodies were from Cell Signaling Technology (Danvers, MA, USA). Rabbit anti-flotillin (RRID: AB_ 941621) was from Abcam (Cambridge, UK). Mouse anti-calnexin (RRID: AB_397884), goat anti-mouse IgG (H+L) antibody (RRID: AB_228307), and Hoechst-33342 fluorescent stain were from Thermo Fischer Scientific (Waltham, MA, USA). Chemiluminescent kit for western blot was from Cyanagen (Bologna, Italy). Ultima gold was from Perkin Elmer (Waltham, MA, USA). 4-20% Mini-PROTEAN â TGX TM Precast Protein Gels, Criterion TGX TM Precast Gels, Turbo Polyvinylidene difluoride (PVDF) Mini-Midi membrane, and DC TM protein assay kit were from BioRad (Hercules, CA, USA). High-performance thin-layer chromatography (HPTLC) and Triton X-100 were from Merk Millipore (Frankfurten, Germany). Polyvinylidene difluoride (PVDF) membrane was from GE Healthcare Life Sciences (Chigago, IL, USA).
Preparation of ganglioside GM1 and its oligosaccharide GM1 ganglioside was purified from the total ganglioside mixture extracted from fresh pig brains collected at the slaughterhouse of the Galbani company (Melzo, Italy), according to the procedure developed previously (Tettamanti et al. 1973) . The ganglioside mixture, 5 g as sialic acid, was dissolved in pre-warmed (36°C) 500 mL of 0.05 M sodium acetate, 1 mM CaCl 2 buffer, pH 5.5. Vibrio cholerae sialidase (1 unit) was added to the solution every 12 h (Acquotti et al. 1994) . Incubation at 36°C and under magnetic stirring was maintained for 2 days, and the solution dialyzed at 23°C for 4 days against 10 L of water changed five times a day. The sialidase-treated ganglioside mixture was subjected to 150 9 2 cm silica gel 100 column chromatography equilibrated and eluted with chloroform/methanol/water, 60 : 35 : 5 by vol. The fractions containing GM1, identified by TLC, were pooled, dried, and submitted to a further column chromatographic purification using the above experimental conditions. Fractions containing pure GM1 were collected and dried. The residue was dissolved in chloroform/ methanol (2:1 v/v) and precipitated by adding four volumes of cold acetone. After centrifugation (15 000 g), the GM1 pellet was separated from the acetone, dried, dissolved in 50 mL of deionized water, and lyophilized giving 1350 mg of white powder which was stored at À20°C.
GM1 containing tritium at position 6 of external galactose was prepared by enzymatic oxidation with galactose oxidase followed by reduction with sodium boro[ 3 H]hydride (Sonnino et al. 1996) were prepared by ozonolysis followed by alkaline degradation (Wiegandt and Bucking 1970) , from GM1 and [ 3 H]GM1, respectively. Altogether, NMR, MS, HPTLC, and autoradiographic analyses showed a homogeneity over 99% for all the prepared gangliosides and oligosaccharides (data not shown).
Tritium-labeled and photoactivable GM1, 1 and 2, and GM1 oligosaccharide, 3 (Fig. 1) , were prepared according to the scheme reported in supplementary materials (Figs. S1, S2, and S3) as previously reported, respectively, in Mauri et al. 2004; Prioni et al. 2004, and Chiricozzi et al. 2017. Photoactivable GM1 oligosaccharide, 3, [6-3 H-IVGal-]OligoGM1-N 3, bearing the photosensitive group on the glucose as well as photoactivable GM1, 1, [6-3 H-IVGal-]GM1-N 3 , bearing the photoactivable group on the fatty acid moiety, was prepared from galactose-tritiated GM1. Photoactivable GM1, 2, [3-3 H-Sph-]GM1-N 3 , bearing the photoactivable group linked at position 6 of external galactose, was prepared from GM1 tritiated at position 3 of the sphingosine.
Briefly, to prepare photoactivable OligoGM1, 52 lmoles of II 3 Neu5Ac-[ 3 H]Gg 4 (0.5 Ci/mmol) was dissolved in 33% ammonia and treated with 1 mg of ammonium hydrogen carbonate. The reaction was maintained under stirring for 48 h at 40°C. The solution was then immediately freeze-dried (Lubineau et al. 1995) . The same approach was followed for the preparation of photosensitive GM1 on the external galactose. In this case, however, tritiated GM1 was firstly subjected to enzymatic oxidation at position 6 of the last galactose.
To insert the photoactivable group on fatty acid residue, galactose-tritiated GM1 was firstly submitted to alkaline hydrolysis to remove the stearic acid residue, followed by acid coupling with 12-aminododecanoic acid. The reaction occurred adding 350 lmol of 12-aminododecanoic acid, dissolved in 2.5 mL of dry tetrahydrofuran (12.5%, v/v) to 1.5 mL of dimethylformamide (7.5%) containing 80 lmoles of deacyl-GM1, 1 mL of Triton X-100 (5%, v/v), and 15 mL of dry triethylamine (75%, v/v). The reaction mixture was maintained under continuous magnetic stirring for 24 h at 23°C. The mixture was evaporated under vacuum to 1, and 25 mL of ethyl acetate was added (Sonnino et al. 1989) .
Finally, all the aminoderivatives were properly treated to insert the chosen photoactivable group. In particular, the azide-labeling procedure started with the dissolution of the crude aminoderivatives obtained by previous reaction in 0.5 mL of dry dimethylformamide. Then, 1 mg of 2-nitro-4-fluoro-phenylazide and 1 lL of tributylamine in 25 lL of dry dimethyl sulfoxide were added under dark conditions. Maintaining dark conditions for the entire process, the reaction mixture was stirred overnight at 80°C. After solvent evaporation, the photoactivable compounds were purified by flash chromatography using chloroform/methanol/2-propanol/water, 60:35:5:5 v/v/v/v as eluent for GM1 oligosaccharide ) and chloroform/methanol/ water, 60:35:8 v/v/v for GM1 (Sonnino et al. 1989) . All the derivates were solubilized in methanol and stored at 4°C.
HPTLC analyses were performed using the solvent system chloroform/methanol/0.2% CaCl 2 , 60:35:8 by vol. Bound sialic acid was determined by the resorcinol-HCl method (Svennerholm 1957; Takki-Luukkainen and Miettinen 1959) , pure Neu5Ac being used as the reference standard.
Cell cultures
N2a cells were cultured and propagated as monolayer in Dulbecco's modified Eagles' medium-high glucose medium supplemented with 10% heat inactivated FBS, 1% L-glutamine, and 1% penicillin/ streptomycin, at 37°C in a humidified atmosphere of 95% air/5% CO 2 . Cells were subcultured to a fresh culture when growth reached the 80-90% confluence (i.e., every 3-4 days). To verify the authentication of employed N2a cells, we performed the following tests at the beginning and end of single experimental work.
Morphology check by microscope
To identify the state of cells, we checked cellular morphology by phase contrast microscopy (Olympus BX50 microscope; Olympus, Tokyo, Japan). Morphological outcomes of N2a cells confirmed the expected neuronal/ameboid-like morphology (data not shown).
Growth curve analysis
Cell proliferation was evaluated according to MTT method (Mosmann 1983; Chiaretti et al. 2016) . Briefly, 2.4 mM MTT (4 mg/mL in PBS) was added to each well and plates were re-incubated for 4 h at 37°C. Medium was carefully removed and replaced with 2-propanol: formic acid, 95:5 (v/v). Plates were gently agitated prior to read the absorbance at 570 nm with a microplate spectrophotometer (Wallac 1420 VICTOR2TM, Perkin Elmer). The growth profile showed a normal growth rate (data not shown).
Mycoplasma detection
Mycoplasma infection was evaluated by fluorescent Hoechst staining (Aureli et al. 2012 ), a fluorescent dye that binds specifically to DNA and that reveals the presence of mycoplasma infections as extracellular particulate or filamentous fluorescence at 400X magnification using NikonEclipse Ni upright microscope. The mycoplasma test has always given negative results (data not shown).
Ganglioside and oligosaccharide treatments N2a cells were plated at 5 9 10 3 /cm 2 and incubated for 24 h to allow cells attachment and recovery in complete medium before all treatments.
To induce neurodifferentiation, growth medium was removed and cells were pre-incubated in pre-warmed (37°C) Transfectagro TM medium containing 2% FBS, 1% L-glutamine, 1% penicillin/ streptomycin, for 30 min at 37°C. Sequentially, cells were incubated at 37°C in the presence of 50 lM gangliosides or oligosaccharides .
Fate of GM1 oligosaccharide photoactivable derivative to N2a cells Fate of GM1 oligosaccharide photoactivable derivative to N2a cells was determined using tritium-labeled [6-H-IVGal-]OligoGM1-N 3 internalized -trypsin stable fraction. The radioactivity associated to each fraction was determined by liquid scintillation counting using a beta-counter system (PerkinElmer). The entire procedure was performed in dark condition under red safelight omitting cell UV illumination to induce photoactivation. The procedure was established previously to determine the fate of gangliosides administered to cells in culture (Chigorno et al. 1985; Chiricozzi et al. 2017) .
Photolabeling experiments
To study the interplay between GM1 and TrkA, cells were incubated with 50 lM of compound 1, 2, or 3 (Fig. 1) , for 3 h at 37°C in the dark. After incubation, medium was removed and cells were illuminated for 40 min under UV light (k= 360 nm) on ice to induce photoactivation. All the procedures before exposure to UV light were performed under red safelight. The cells were lysed and subjected to 4-20% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred on PVDF membrane. Digital autoradiography of the PVDF membrane was performed with Beta-Imager 2000 (Biospace, Paris). The same PVDF membrane was then incubated with anti-TrkA antibody following a blocking step in 5% non-fat milk in TBS-Tween 0.1% (Sonnino et al. 1989 (Sonnino et al. , 1992 Chigorno et al. 1990; Loberto et al. 2003; Chiricozzi et al. 2015 Chiricozzi et al. , 2017 .
Isolation of detergent-resistant membrane (DRM) fractions
To verify the presence of TrkA in the plasma membrane microdomain, N2a cells were incubated in the absence (control) or in the presence of 50 lM GM1 or 50 lM OligoGM1 for 3 h at 37°C. detergent-resistant membrane (DRM) were prepared by ultracentrifugation on discontinuous sucrose gradient of cells subjected to homogenization with 1% Triton X-100, as previously described (Chiricozzi et al. 2015; Schiumarini et al. 2017) . Briefly, cells were mechanically harvested in PBS 1X and centrifuged at 270 9 g for 10 min at 4°C. Cell pellet was lysed in 1.2 mL of 1% Triton X-100 in TNEV buffer (10 mM TrisHCl 10, 150 mM NaCl, 5 mM EDTA pH 7.5) in the presence of 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, and 75 mU/mL aprotinin and homogenized for 11-folds with tight Dounce. Cell lysate (2 mg of cell protein/mL) was centrifuged for 5 min at 1300 g at 4°C to remove nuclei and cellular debris and obtain a postnuclear supernatant (PNS). A volume of 1 mL of PNS was mixed with an equal volume of 85% sucrose (w/v) in TNEV buffer containing 1 mM Na 3 VO 4 , placed at the bottom of a discontinuous sucrose gradient (30-5%), and centrifuged for 17 h at 200 000 g at 4°C. After ultracentrifugation, 12 fractions were collected starting from the top of the tube. The light scattering band, corresponding to the DRM fraction, was located at the interface between 5 and 30% sucrose corresponding to fraction 5 or 6. The entire procedure was performed at 0-4°C on ice immersion. Equal amounts from each fraction were used for protein and lipid analysis.
Protein analysis
Equal amounts of proteins derived from photolabeled cells from gradient fractions or from GM1/OligoGM1-treated/untreated cells were denatured, separated on 4-20% polyacrylamide gels, and transferred to PVDF membranes using the Trans-Blot â Turbo TM Transfer System (Bio-Rad). The presence of TrkA, Flotillin, or Calnexin was determined by specific primary antibody, followed by reaction with secondary HRP-conjugated antibody.
For the time course analysis of TrkA-ERK1/2 activation, proteins derived from GM1/OligoGM1-treated and -untreated cells were denatured, separated on 7.5% polyacrylamide gels, and transferred to PVDF membranes. The presence of TrkA, p-TrkA, ERK1/2, and p-ERK1/2 was determined by specific primary antibodies, followed by reaction with secondary HRP-conjugated antibodies.
The data acquisition and analysis were performed using Alliance Uvitec (Cleaver Scientific, United Kingdom).
Protein determination
Protein concentration of samples was assessed using a DC TM protein assay kit according to manufacturer's instructions, using bovine serum albumin as standard.
Lipid extraction and GM1 detection Sucrose fractions were dialyzed, lyophilized, and subjected to lipid extraction. Total lipids were extracted with chloroform/methanol/ water, 20 : 10 : 1 by vol, followed by a second extraction with chloroform/methanol, 2 : 1 by vol (Prinetti et al. 2011; Chiricozzi et al. 2014; Samarani et al. 2018) . Lipids were separated by Thin Layer Chromatography (TLC); then, GM1 ganglioside was specifically detected with HPR-conjugated cholera toxin B (CT-B) staining directly on TLC (Wu and Ledeen 1988; Valperta et al. 2007; Chiricozzi et al. 2018a ). Briefly, sample was spotted on a silica gel 60 HPTLC plate and developed in chloroform/methanol/0.2% aqueous CaCl 2 , 50:42:11 by vol. Following solvent evaporation, the plate was treated for 30 s with a solution of 0.2% (v/v) polyisobutylmethacrilate in hexane for three times and air-dried for 1 h. After 1 h of preincubation at 23°C in PBS containing 3% BSA (w/v), the plate was overlaid with CT-B subunit-HPR conjugated (40 ng) in 1% BSA (w/ v) at 23°C for 1 h. After washing three times with PBS, plates were developed with o-phenylenediamine (one tablet in 1.8 mL of citratephosphate buffer 0.05 M (pH 5) and 17 lL of H 2 O 2 ).
Morphological analysis
Cultured cells, treated or not with GM1 or OligoGM1, were observed by phase contrast microscopy (200x magnification, Olympus BX50 microscope; Olympus, Tokyo, Japan). At least 10 fields from each well were photographed for each experiment.
Statistical analysis
Data are expressed as mean AE SEM. The normality of data was not assessed because the number of the samples was too small. Thus, data were analyzed for significance by Mann-Whitney test. The analysis was performed with Prism software (GraphPad Software, Inc. La Jolla, CA, USA).
Other analytical methods NMR spectra were recorded with a Bruker AVANCE-500 spectrometer at a sample temperature of 298 K. NMR spectra were recorded in CDCl3 or CD3OD and calibrate using the TMS signal as internal reference.
Mass spectrometric analysis were performed in positive or negative ESI-MS. MS spectra were recorded on a Thermo Quest Finningan LCQTM DECA ion trap mass spectrometer, equipped with a Finnigan ESI interface; data were processed by Finnigan Xcalibur software system. All reactions were monitored by TLC on silica gel 60 plates (Merck).
Radioactivity associated with cells and trypsin and serum labile cell fractions was determined by liquid scintillation counting. Digital autoradiography of the PVDF membranes was performed with a Beta-Imager 2000 (Biospace, Paris).
No randomization or blinding procedures were performed for our experiments.
Institutional approval was not needed. The study was not preregistered. No sample calculation was performed to predetermine the sample size.
No test for outliers was conducted because all the data obtained were included in the analysis.
Custom-made materials will be shared upon reasonable request. The n number (n=) in the figure legend indicates the number of independent cell culture preparations.
Results
Time course of the TrkA-ERK1/2 signaling pathway The ability of GM1 and its oligosaccharide, OligoGM1, to activate the TrkA-MAPK pathway after 24-48 h from their exogenous administration, has been reported .
In order to examine the time course of TrkA-ERK1/2 pathway activation induced by GM1 and its oligosaccharide, OligoGM1, the phosphorylation levels of TrkA on Tyr490 and of Erk1/2 on Thr202/Tyr204 were followed by immunoblotting analysis.
As shown in Fig. 2 , GM1 and OligoGM1 caused a rapid elevation of TrkA phosphorylation, detectable right after 30 min, and significantly maintained for over the 12-h time course. The enhancement in ERK1/2 phosphorylation appeared successively, getting significant after 6 h from GM1 and OligoGM1 administration (Fig. 2) . The results revealed that, following GM1 and OligoGM1 treatment, TrkA Tyr490 phosphorylation increased twofold in 3 h and Erk1/2 phosphorylation doubles in 6 h, respect to control untreated cells. Both proteins remained hyperphosphorylated for the following 24-48 h . In parallel, the morphological analysis revealed the acquisition of neuron-like morphology of N2a cells (sprouting and elongation of neuritis), confirming that the differentiation processes occurred (Fig. 2) .
Photolabeling experiments
The ability of GM1 to directly, tightly, and specifically associate with TrkA has been demonstrated by Mutoh (Mutoh et al. 1995) . To characterize in detail which molecular part of GM1 is delegated to the interaction with TrkA receptor, we performed photolabeling experiments using the tritium-labeled gangliosides 1 and 2 with the photoactivable group carried by ceramide and external galactose, respectively, and the tritium-labeled GM1 oligosaccharide 3 with the photoactivable group carried by glucose. Fig. 1 reports the three structures generated in our laboratory according to the scheme described in Figs. S1, S2, and S3 as indicated in supplementary section (Sonnino et al. 1989; Mauri et al. 2004; Prioni et al. 2004; Chiricozzi et al. 2017) .
Previous information reported that under controlled conditions, ganglioside derivatives 1 and 2 administered to the cells are taken up by the cells and incorporated into the cell plasma membrane with metabolic results that are indistinguishable from the endogenous GM1 ganglioside (Sonnino et al. 1989; Mauri et al. 2004; Prioni et al. 2004) . Differently, the GM1 oligosaccharide derivative 3 does not enter into the cells nor inserts in the plasma membrane but interacts in a non-covalent manner with the cell surface as shown in Figure S4 .
N2a cells were incubated for 3 h at 37°C with the photosensitive derivatives, under dark conditions, and illuminated by UV-light for 40 min at 4°C to induce covalent cross-linking between radioactive derivatives and neighboring cell components. Under UV irradiation, the azide of the nitrophenylazide group becomes a nitrene, that immediately generates covalent bonds with adjacent molecules, because of its high reactivity. In this way, proteins interacting with the azide-bearing radioactive molecules become radiolabeled as well (Sonnino et al. 1989) . Cell proteins were separated by SDS-PAGE, transferred on a PVDF membrane, and visualized by digital autoradiography as well as by colorimetric assay. Among the entire N2a protein pattern (Fig. S5, line 2) , only few radioactive bands were detected on PVDF (Fig. S5, line 1) . The radioactive tracks identify proteins cross-linked with the photoactivated compound; therefore, proteins that were in proximity to photoactivable compound before illumination. A radioactive protein pattern was identified using both the ganglioside derivatives 1 and 2 incorporated into the plasma membranes as well as using the oligosaccharide derivative 3 that was not taken up by the cells. In the three experimental models, the difference between the protein and the radioactive protein patterns suggests specific protein-ganglioside and proteinoligosaccharide interactions (Fig. 3) .
Following the autoradiography, the PVDF membranes were immunostained with anti-TrkA antibody. The band corresponding to TrkA signal was found to perfectly overlap a radiolabeled band at 140 kDa in cells treated with ganglioside derivative 2, carrying the photoactivable group on the external galactose and with the oligosaccharide derivative 3, carrying the photoactivable group on the glucose (Fig. 3b and c) . No correspondence of TrkA signal with radioactive track was found when cells were treated with the GM1 derivative 1, carrying the photoactivable group at the end of ceramide (Fig. 3a) .
These results suggest that the TrkA-GM1 complex formed through the interaction between the TrkA and the oligosaccharide head of the ganglioside GM1 does not involve the presence of ceramide portion in proximity to the receptor.
Membrane lipid domains characterization
The above results support the hypothesis that TrkA and GM1 inserted into the external lipid layer of the plasma membrane are near enough to interact. Contrary to this possibility, there are previous information reporting that the ganglioside GM1 Fig. 3 Interaction between TrkA and GM1 in N2a cells. Photoactivable derivatives of GM1 were administered to N2a cells and cells were then illuminated. Proteins of cell lysate were submitted to 4-10% acrylamide SDS-PAGE, transferred on PVDF membrane, and visualized by digital autoradiography for 96 h (right). The same PVDF was blotted using specific antibody anti-TrkA (left). The images are representative of three independent cell culture preparations. (a) Interaction between TrkA and [Gal-6-localizes in lipid membrane domains, the lipid rafts, and that the TrkA receptor places in the fluid membrane environment separated from the lipid rafts (Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012) .
To better understand this point, after treating N2a cells with GM1 ganglioside or with its oligosaccharide, lipid rafts were isolated as the DRM, according to the procedure described in Methods section.
Lipids were extracted from each fraction, separated by HPTLC and ganglioside GM1 content was revealed by TLCstaining with cholera toxin B subunit (CT-B). In all experimental conditions (control cells, GM1-treated cells, and GM1 oligosaccharide-treated cells), GM1 was found in the rigid membrane fractions non-solubilized by the detergent (Fig. 4) , which is in total agreement with the large information available from the literature (Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012) . Differently, in any experimental condition, western blotting analysis revealed that TrkA was present in the fluid membrane fraction, solubilized by the detergent (Fig. 4) . This result supports the photoactivable data and highlights that TrkA and GM1 interact through the oligosaccharide chain in the extracellular environment since GM1 and TrkA belong to separate membrane portions.
Discussion
Gangliosides are amphiphilic compounds with a good balance between the hydrophilic head, represented by the oligosaccharide group, and the highly hydrophobic ceramide (Sandhoff et al. 2018) . The gangliosides oligosaccharide protrudes into the extracellular environment where may interact with the extracellular part of the other membrane components, while the ceramide is inserted into the lipid membrane layer serving to anchor the total structure in restricted membrane areas known as 'lipid rafts' (Sonnino et al. 2006 . It is believed that, in the lipid rafts, sphingolipids modulate the functional features of several membrane proteins (Coskun and Simons 2011) . Since gangliosides are highly segregated together with cholesterol Fig. 4 Sucrose gradient fractions characterization. N2a cells were incubated in the absence (a, control) or in the presence of 50 lM GM1 (b) or 50 lM OligoGM1 (c) for 3 h at 37°C. Cells were subsequently subjected to sucrose gradient ultracentrifugation to prepare plasma membrane microdomains. Twelve fractions were collected from the top of the tube, with fractions 4-6 corresponding to the detergentresistant membrane (DRM) fractions and fractions 10-12 corresponding to high density (HD) fractions. Left: Immunoblotting against the TrkA, calnexin (HD marker), and flotillin (DRM marker) performed on postnuclear supernatant (PNS) and on the 12 fractions. Images are representative of three independent cell culture preparations. Right: GM1 detection among total lipids extracted from each sucrose fraction, revealed by cholera toxin subunit B (CT-B) TLCstaining (std: GM1 standard).
in liquid-ordered lipid domains with locally reduced fluidity (Sonnino et al. 2006; Grassi et al. 2018) , it is suggested that proteins co-segregating with them display a restricted lateral motility. Such microenvironment characterized by stable interactions results instrumental for ganglioside-dependent protein-specific fine modulation. In addition, glycosphingolipid oligosaccharide chains are recognized by soluble ligands, such as that of GM1 by cholera toxin (Svennerholm 1976) and that of neutral glycolipid Gb 3 Cer by verotoxin (Lingwood 1999; Chiricozzi et al. 2018b) . Moreover, the GD1a and GT1b oligosaccharide chains interact with the myelin-associated glycoprotein (Schnaar and Lopez 2009) belonging to the interfacing membrane of adjacent cells.
However, in most cases, the molecular mechanisms underlying the modulatory effect of gangliosides on the protein functions remain obscure.
The increase in GM1 at the cell surface, obtained with any experimental strategy, promotes neurite production and cell differentiation in neuroblastoma cells (Facci et al. 1984; Farooqui et al. 1997; Rodriguez et al. 2001; Mutoh et al. 2002; Da Silva et al. 2005; Valperta et al. 2007; Schneider et al. 2015) . Experimental results indicate that this is because of TrkA activation by GM1 (Ferrari et al. 1995; Mutoh et al. 1995 Mutoh et al. , 2002 Rabin and Mocchetti 1995; Farooqui et al. 1997; Duchemin et al. 2002; Rabin et al. 2002) and more in detail, because of the interaction between TrkA and the head group of GM1, its oligosaccharide . In PC12 cells, where GM1 in the absence of nerve growth factor (NGF) is not able to induce neurodifferentiation (Ferrari et al. 1983) , the GM1 association with TrkA strongly improves neurite outgrowth and neurofilament protein expression elicited by a low dose of NGF, inducing a threefold increase in NGF-induced Trk autophosphorylation (Mutoh et al. 1995) . Important to note that NGF, even if not synthetized by N2a cells (Leon et al. 1994) , is present in our experimental condition since the culture medium used contains serum . Molecular dynamics calculations suggest that hydrogen bonds and ionic interaction between sugars and TrkA-NGF amino acids stabilize a TrkA-NGF-GM1 complex . This means that the ganglioside oligosaccharide is not more distant than 4-5 A from the receptor, during the interaction. GM1 belongs to a rigid membrane environment and is considered one of the markers of lipid rafts. It is reported that TrkA is associated to a membrane fluid environment displaying, at least under specific conditions, some dynamics (Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012) . Here, we fractionated the total cell homogenate prepared from cells treated, or not treated, with ganglioside GM1 or its oligosaccharide and, in agreement with the available information, GM1 was found in the rigid membrane fractions while TrkA was found in the fluid fraction solubilized by the detergent (Fig. 4) .
From our previous results, we know that the ceramide portion of GM1 is not necessary for the TrkA activation , and the results on the membrane topology of TrkA and GM1 suggest that GM1 ceramide is not strictly part of the environment of TrkA. To better understand how the TrkA-GM1 interaction occurs, we synthesized three tritium-labeled photoactivable compounds ( Fig. 1) : (i) GM1 carrying the photoactivable group linked at the end of the acyl moiety, (ii) GM1 carrying the photoactivable group linked to the external galactose, and (iii) the free GM1 oligosaccharide with the photoactivable group linked to glucose.
The three compounds were added to the cell medium. We know that, under established and here used conditions, the GM1 derivative administered to the cells is taken up by the cells becoming component of the cell plasma membranes and metabolically indistinguishable from the endogenous GM1 (Sonnino et al. 1989) . On the contrary, the GM1 oligosaccharide is not taken up by the cells (Fig. 4S ).
Cells were UV illuminated and proteins analyzed for their tritium content, mirror of the stable cross linkage of the proteins with the photoactivated compound (Fig. 3) . TrkA resulted cross-linked to the GM1 oligosaccharide and to the GM1 carrying the photoactivated group on the position 6 of external galactose, but not with GM1 carrying the photoactivable group at the end of the acyl chain and located in the middle of membrane double layer. This result suggests that the distance between the GM1 ceramide moiety and the transmembrane portion of TrkA is too wide to establish the covalent linkage. This is in agreement with the result indicating that TrkA is detergent soluble, while GM1 is not (Fig. 4) .
It is reported that, at least keeping precise conditions, TrkA, that shows high dynamics within the membrane components, moves from fluid to rigid environments (Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012) . According to this, we should consider that the administration of GM1 to the cells, and its incorporation into the membrane rigid domain (Facci et al. 1984; Limpert et al. 2007; Ichikawa et al. 2009; Pryor et al. 2012) , allows to reach a GM1 membrane concentration high enough to block the dynamics of TrkA, forming then the TrkA-GM1 complex through a TrkA-GM1 oligosaccharide interaction. Thus, when the TrkA approaches the boarder of the lipid rafts because of its dynamics in the fluid membrane, the extracellular environment of the soluble portion of TrkA, with an extension of the order of several tens of A, may reach the GM1 oligosaccharide with no necessity for TrkA to belong to the same lipid membrane domain of GM1.
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